1,216 results on '"Dijkmans, B A"'
Search Results
2. Role of Multidrug Resistance Proteins (MRP) in Resistance to Antifolates and Folate Homeostasis
3. A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides
4. Combination treatment in autoimmune diseases — Introduction
5. Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus
6. Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy
7. Elevated liver enzymes in patients with ankylosing spondylitis treated with etanercept
8. High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review
9. High frequency of vertebral fractures in early spondylarthropathies
10. High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis
11. Efficacy of serology driven “test and treat strategy” for eradication of H. pylori in patients with rheumatic disease in the Netherlands
12. Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies
13. Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritis
14. Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers
15. Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis
16. Expression of a pathogen-response program in peripheral blood cells defines a subgroup of Rheumatoid Arthritis patients
17. 2-Deoxy-2-[F-18]fluoro-D-glucose Joint Uptake on Positron Emission Tomography Images: Rheumatoid Arthritis Versus Osteoarthritis
18. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial
19. The effect of intravenous pamidronate versus oral alendronate on bone mineral density in patients with osteoporosis
20. Neurologic dysfunction in patients with rheumatoid arthritis of the cervical spine. Predictive value of clinical, radiographic and MR imaging parameters
21. Prevention of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty: a continuing matter of debate
22. Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRÉ Study
23. Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients
24. Chloroquine Therapy in Patients with Recent-Onset Rheumatoid Arthritis: The Clinical Response can be Predicted by the Low Level of Acute-Phase Reaction at Baseline
25. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis
26. Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study
27. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
28. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative
29. Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis
30. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase
31. Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: A case series and cohort study
32. A comparison between the simplified erosion and narrowing score and the Sharp–van der Heijde score: post hoc analysis from the BeSt study
33. Development of the anticitrullinated peptide antibody repertoire prior to the onset of rheumatoid arthritis
34. Rheumatoid arthritis: involvement of the synovium in the preclinical phase?
35. Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study
36. A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study
37. Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab
38. Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study
39. The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better
40. Identification of anti-TNF candidates based on predicted response and remission in ankylosing spondylitis: 0464
41. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis
42. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study
43. Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study
44. Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis
45. Ankylosing spondylitis: a risk factor for myocardial infarction?
46. Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial
47. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study
48. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
49. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis
50. The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.